Effect of Vitamin D Treatment in Primary Hyperparathyroidism
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The primary aim of the study is to assess whether 6-months of vitamin D supplements can
decrease PTH compared with placebo treatment in primary hyperparathyroidism.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Aarhus
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins